University of Kentucky

University of Kentucky was paid $716.41M by Medicaid between Jan 2018 and Dec 2024, across 1220 billing codes. Its largest line is 99284, emergency room visit (serious) — 9.9% of everything it billed.

Compared with peers

Next to other Ambulance providers in Kentucky

Rank by total paid#1 of 52

Median peer was paid$431K

This provider vs. median1,662×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	1,023,282	$77.93M
2019	1,054,973	$86.21M
2020	1,001,755	$77.89M
2021	1,326,837	$90.11M
2022	1,504,788	$125.08M
2023	1,585,360	$148.31M
2024incomplete	1,320,202	$110.89M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	9.9%	168,001	143,108	$70.97M
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	6.1%	56,290	48,248	$43.48M
G0463	Hospital outpatient clinic visit for assessment and management of a patient	4.1%	596,543	480,956	$29.16M
J9271	Injection, pembrolizumab, 1 mg	4.0%	2,989	2,284	$28.96M
74177	Computed tomography, abdomen and pelvis; with contrast material	3.2%	28,651	24,881	$22.88M
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	2.9%	74,551	66,461	$20.63M
77386		2.0%	21,968	1,941	$14.05M
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	1.9%	267,242	220,241	$13.59M
G0378	Hospital observation service, per hour	1.9%	55,687	23,096	$13.33M
J9299	Injection, nivolumab, 1 mg	1.6%	1,407	974	$11.38M
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	1.4%	11,822	10,774	$10.32M
J1745	Injection, infliximab, excludes biosimilar, 10 mg	1.3%	2,201	1,886	$9.51M

1208 more codes

93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	1.1%	13,544	$8.19M
J1561	Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg	1.0%	4,061	$7.20M
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	14,392	$6.96M
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	<1%	8,577	$6.70M
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	<1%	28,927	$6.44M
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	102,677	$6.36M
80053	Comprehensive metabolic panel	<1%	361,020	$6.35M
J3380	Injection, vedolizumab, intravenous, 1 mg	<1%	989	$6.03M
71275	Computed tomographic angiography, chest, with contrast material	<1%	11,778	$5.83M
70450	Computed tomography, head or brain; without contrast material	<1%	21,203	$5.75M
70496		<1%	8,741	$5.51M
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	<1%	38,541	$5.45M
78815	Positron emission tomography (PET) for limited area imaging	<1%	3,644	$4.91M
99282	Emergency department visit for the evaluation and management, low to moderate severity	<1%	31,358	$4.70M
96375	Therapeutic injection; each additional sequential IV push	<1%	54,415	$4.63M
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	<1%	6,694	$4.53M
G0482	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed	<1%	28,679	$4.27M
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	86,167	$4.25M
70498		<1%	8,204	$4.16M
72125	Computed tomography, cervical spine; without contrast material	<1%	10,817	$4.16M
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	6,952	$4.15M
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	30,748	$4.12M
71045	Radiologic examination, chest; single view	<1%	47,453	$4.00M
J0585	Injection, onabotulinumtoxina, 1 unit	<1%	5,097	$3.96M
99291	Critical care, evaluation and management of the critically ill patient, first 30-74 minutes	<1%	2,977	$3.47M
69436	Tympanostomy (requiring insertion of ventilating tube), general anesthesia	<1%	3,895	$3.45M
42820	Tonsillectomy and adenoidectomy; younger than age 12	<1%	2,812	$3.45M
74174		<1%	4,320	$3.39M
71046	Radiologic examination, chest; 2 views	<1%	36,349	$3.34M
36415	Collection of venous blood by venipuncture	<1%	560,344	$3.28M
96361	Intravenous infusion, hydration; each additional hour	<1%	30,821	$3.23M
93975		<1%	8,889	$3.17M
41899	Unlisted procedure, dentoalveolar structures	<1%	2,689	$3.14M
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	15,559	$3.14M
G0483	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed	<1%	19,708	$3.11M
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	272,515	$3.07M
C1776	Joint device (implantable)	<1%	1,188	$3.01M
70551	Magnetic resonance imaging, brain; without contrast material	<1%	4,209	$2.80M
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	9,178	$2.79M
70491		<1%	5,515	$2.74M
95810	Polysomnography; sleep staging with 4 or more additional parameters	<1%	2,655	$2.74M
74183		<1%	3,359	$2.68M
72131		<1%	7,695	$2.67M
71250		<1%	8,721	$2.53M
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	<1%	40,790	$2.46M
72128		<1%	6,565	$2.40M
76770		<1%	9,880	$2.38M
95715		<1%	2,458	$2.33M
70486		<1%	6,210	$2.26M
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	41,079	$2.20M
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	12,469	$2.17M
49083		<1%	3,457	$2.12M
Q5107	Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg	<1%	804	$2.12M
G0390	Trauma response team associated with hospital critical care service	<1%	1,337	$2.05M
73630		<1%	20,589	$2.03M
93325		<1%	11,425	$1.99M
C1889	Implantable/insertable device, not otherwise classified	<1%	7,630	$1.98M
77412		<1%	9,154	$1.97M
47562		<1%	743	$1.95M
45380	Colonoscopy, flexible; with biopsy, single or multiple	<1%	2,963	$1.93M
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	31,709	$1.85M
72197		<1%	2,213	$1.78M
93304		<1%	6,139	$1.75M
84443	Thyroid stimulating hormone (TSH)	<1%	106,780	$1.66M
87631		<1%	12,634	$1.66M
76830	Ultrasound, transvaginal	<1%	8,826	$1.65M
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	14,967	$1.61M
73610		<1%	17,636	$1.59M
36430		<1%	4,028	$1.58M
67311		<1%	1,115	$1.57M
J2505	Injection, pegfilgrastim, 6 mg	<1%	472	$1.54M
J9312	Injection, rituximab, 10 mg	<1%	306	$1.51M
93303	Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study	<1%	3,685	$1.50M
73562		<1%	15,122	$1.47M
92507	Treatment of speech, language, voice, communication, and/or auditory processing disorder	<1%	19,749	$1.46M
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	<1%	16,945	$1.44M
95816		<1%	4,479	$1.43M
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	41,599	$1.43M
59025	Fetal non-stress test	<1%	8,373	$1.42M
73130		<1%	15,203	$1.36M
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	41,079	$1.35M
76816	Ultrasound, pregnant uterus, real time with image documentation, follow-up	<1%	7,916	$1.33M
Q5103	Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg	<1%	510	$1.32M
74018		<1%	14,522	$1.30M
87636	Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B	<1%	16,254	$1.29M
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	1,742	$1.29M
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	33,642	$1.27M
77301		<1%	979	$1.25M
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	19,084	$1.24M
96415		<1%	7,617	$1.24M
76811	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed	<1%	4,730	$1.23M
Q3014	Telehealth originating site facility fee	<1%	47,176	$1.23M
36591		<1%	26,143	$1.22M
70543		<1%	1,330	$1.22M
77334		<1%	2,320	$1.22M
85027		<1%	155,484	$1.18M
73110		<1%	12,534	$1.16M
88185		<1%	3,578	$1.16M
73030		<1%	12,256	$1.14M
94060		<1%	5,876	$1.13M
73590		<1%	12,253	$1.11M
76642		<1%	7,733	$1.10M
54161		<1%	871	$1.08M
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	89,007	$1.04M
95951		<1%	1,411	$1.00M
93971		<1%	4,943	$990K
93321		<1%	7,057	$988K
77336		<1%	5,889	$986K
64488		<1%	969	$980K
44970		<1%	536	$975K
J9035	Injection, bevacizumab, 10 mg	<1%	213	$967K
73721	Magnetic resonance imaging, any joint of lower extremity; without contrast material	<1%	1,349	$961K
74178		<1%	949	$956K
72141		<1%	1,360	$953K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	42,859	$940K
72156		<1%	967	$940K
80048	Basic metabolic panel (calcium, ionized)	<1%	77,294	$930K
94010		<1%	9,983	$929K
72100		<1%	7,952	$925K
75561		<1%	1,218	$907K
45385	Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s)	<1%	1,490	$900K
84484		<1%	39,693	$897K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	13,999	$892K
72158		<1%	975	$871K
73080		<1%	10,017	$864K
88307		<1%	5,600	$861K
C1769	Guide wire	<1%	13,085	$860K
96376		<1%	12,449	$852K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	19,116	$838K
96417		<1%	6,578	$824K
87902		<1%	3,747	$807K
43264		<1%	697	$795K
19083		<1%	534	$793K
76536		<1%	5,136	$790K
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	17,767	$781K
J2350	Injection, ocrelizumab, 1 mg	<1%	45	$778K
87522	Neg quan hep c or qual rna	<1%	18,286	$771K
43235		<1%	1,864	$762K
36561		<1%	488	$755K
93308		<1%	3,582	$753K
A9585	Injection, gadobutrol, 0.1 ml	<1%	23,446	$751K
87536		<1%	10,785	$748K
73700		<1%	1,981	$747K
62323		<1%	956	$745K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	5,525	$742K
64493		<1%	901	$741K
81229		<1%	1,011	$739K
73090		<1%	9,159	$738K
Q5118	Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg	<1%	468	$737K
80061	Lipid panel	<1%	57,174	$725K
J0185	Injection, aprepitant, 1 mg	<1%	3,151	$717K
82805		<1%	14,122	$715K
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	1,038	$711K
73552		<1%	8,727	$701K
D7140	Extraction, erupted tooth or exposed root	<1%	1,905	$686K
58571		<1%	260	$685K
83036	Hemoglobin; glycosylated (A1C)	<1%	76,022	$685K
76857		<1%	2,805	$674K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	15,054	$665K
96367		<1%	6,351	$664K
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	8,808	$658K
J7050	Infusion, normal saline solution, 250 cc	<1%	62,901	$638K
77338		<1%	1,131	$629K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	2,426	$627K
83605		<1%	44,915	$620K
J9355	Injection, trastuzumab, excludes biosimilar, 10 mg	<1%	138	$619K
20680		<1%	377	$617K
88304		<1%	9,172	$616K
72040		<1%	5,469	$609K
J2506	Injection, pegfilgrastim, excludes biosimilar, 0.5 mg	<1%	224	$609K
77300		<1%	1,788	$597K
93970		<1%	2,153	$585K
P9016	Red blood cells, leukocytes reduced, each unit	<1%	1,992	$582K
88341		<1%	3,898	$576K
76000		<1%	4,751	$575K
C1726	Catheter, balloon dilatation, non-vascular	<1%	2,720	$574K
11042	Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm	<1%	2,713	$573K
87507		<1%	2,189	$572K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	3,985	$568K
64615		<1%	2,734	$555K
83735		<1%	77,938	$553K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	34,431	$535K
93017		<1%	1,978	$535K
73060		<1%	6,602	$531K
73502		<1%	7,291	$531K
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	2,334	$527K
83690		<1%	45,952	$525K
20610		<1%	2,073	$516K
C9803	Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	57,864	$514K
87086	Culture, bacterial; quantitative colony count, urine	<1%	55,584	$504K
94726		<1%	4,707	$501K
86480		<1%	9,833	$498K
88342		<1%	7,121	$497K
31624		<1%	731	$496K
73560		<1%	5,628	$493K
52356		<1%	182	$485K
77066	Tomosynthesis, mammo	<1%	4,393	$484K
51798		<1%	5,589	$482K
73120		<1%	4,966	$481K
C1874	Stent, coated/covered, with delivery system	<1%	335	$473K
A9552	Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries	<1%	4,726	$472K
72170		<1%	5,820	$472K
84439		<1%	52,602	$471K
77290		<1%	962	$466K
10060		<1%	2,489	$457K
73221		<1%	642	$453K
96411		<1%	3,035	$452K
76870		<1%	2,374	$452K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	13,842	$449K
95700		<1%	2,743	$447K
78816		<1%	267	$441K
86803		<1%	33,516	$440K
86850		<1%	33,812	$438K
93320		<1%	2,269	$437K
94729		<1%	4,636	$432K
81001		<1%	60,858	$429K
93225		<1%	2,218	$427K
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	5,746	$421K
83880		<1%	14,152	$419K
20553		<1%	1,739	$418K
80074		<1%	9,167	$417K
70480		<1%	1,344	$417K
97161		<1%	6,898	$414K
76801		<1%	2,582	$402K
87040		<1%	11,837	$402K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	6,154	$400K
C1887	Catheter, guiding (may include infusion/perfusion capability)	<1%	2,933	$395K
C1894	Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser	<1%	6,677	$383K
85610		<1%	76,061	$380K
86360		<1%	9,819	$376K
95885		<1%	2,509	$375K
86140		<1%	52,828	$373K
93226		<1%	2,420	$366K
75574		<1%	1,091	$365K
64494		<1%	918	$361K
76819	Fetal biophysical profile; without non-stress testing	<1%	2,027	$357K
31575		<1%	1,402	$355K
A0425	Ground mileage, per statute mile	<1%	6,497	$354K
77065	Tomosynthesis, mammo	<1%	3,693	$354K
81003		<1%	87,197	$353K
84702		<1%	19,835	$353K
36592		<1%	9,042	$351K
72082		<1%	3,269	$350K
86235		<1%	6,982	$349K
95708		<1%	317	$346K
86832		<1%	1,946	$343K
84703		<1%	30,047	$337K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	18,056	$336K
76813		<1%	2,447	$335K
74230		<1%	2,534	$332K
D1120	Dental cleaning, child	<1%	828	$332K
90460	Immunization administration through 18 years of age via any route, first or only component	<1%	36,211	$330K
76942		<1%	2,115	$329K
82565		<1%	30,470	$327K
86833		<1%	1,916	$327K
83970		<1%	9,540	$326K
87581		<1%	9,589	$326K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	1,434	$322K
70487		<1%	844	$319K
73564		<1%	2,719	$318K
C1725	Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability)	<1%	997	$315K
12001		<1%	2,484	$314K
81025		<1%	31,133	$313K
87486		<1%	9,702	$311K
90677		<1%	6,612	$309K
95911		<1%	840	$309K
J2704	Injection, propofol, 10 mg	<1%	91,326	$307K
77295		<1%	187	$305K
45378	Colonoscopy, flexible; diagnostic, including collection of specimen(s)	<1%	522	$303K
95886		<1%	2,128	$303K
86359		<1%	9,827	$302K
82330		<1%	21,032	$296K
64635		<1%	302	$294K
93976		<1%	1,506	$291K
10005		<1%	509	$286K
90378		<1%	385	$283K
64445		<1%	651	$282K
72157		<1%	292	$281K
95806		<1%	1,499	$280K
77080		<1%	2,780	$280K
90651		<1%	4,972	$279K
74160		<1%	673	$277K
42830		<1%	378	$275K
76825		<1%	762	$273K
52332		<1%	275	$262K
58661		<1%	155	$262K
75565		<1%	906	$261K
95819		<1%	836	$258K
86355		<1%	8,622	$258K
G0145	Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision	<1%	11,732	$257K
86357		<1%	8,581	$254K
12011		<1%	2,050	$252K
91200		<1%	2,266	$251K
86900		<1%	34,709	$251K
92611		<1%	1,937	$250K
86703		<1%	16,773	$248K
78830		<1%	262	$246K
J7120	Ringers lactate infusion, up to 1000 cc	<1%	92,554	$246K
82607		<1%	19,819	$244K
72050		<1%	1,657	$243K
76820		<1%	1,922	$243K
72110		<1%	1,429	$243K
J7030	Infusion, normal saline solution , 1000 cc	<1%	50,914	$240K
82728		<1%	20,894	$240K
99218		<1%	869	$238K
36226		<1%	97	$238K
D1206	Topical application of fluoride varnish	<1%	796	$236K
76882		<1%	1,600	$233K
G0481	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed	<1%	2,112	$228K
G0101	Cervical or vaginal cancer screening; pelvic and clinical breast examination	<1%	5,824	$227K
93296		<1%	6,056	$226K
76937		<1%	4,086	$225K
29125		<1%	2,449	$224K
72190		<1%	1,985	$223K
49650		<1%	92	$222K
85730		<1%	31,011	$219K
96409		<1%	2,300	$218K
78306		<1%	511	$217K
73521		<1%	1,797	$216K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	7,545	$215K
82784		<1%	15,787	$213K
87070		<1%	17,022	$212K
75635		<1%	452	$212K
87077		<1%	20,115	$211K
77387		<1%	1,714	$211K
90715		<1%	10,215	$209K
95909		<1%	968	$208K
64447		<1%	538	$208K
52000		<1%	466	$207K
80069		<1%	21,248	$207K
72070		<1%	2,161	$206K
64721		<1%	151	$205K
93880		<1%	961	$205K
97162		<1%	3,560	$203K
A0427	Emergency ambulance ride, advanced life support	<1%	3,758	$202K
96416		<1%	749	$201K
82542		<1%	6,928	$200K
73100		<1%	2,072	$196K
84100		<1%	34,879	$195K
83516		<1%	12,924	$192K
86901		<1%	34,456	$190K
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	91,920	$190K
70355		<1%	2,503	$189K
94618		<1%	1,687	$189K
95712		<1%	413	$189K
J2997	Injection, alteplase recombinant, 1 mg	<1%	1,021	$184K
86780		<1%	14,482	$183K
77063	Screening digital breast tomosynthesis, bilateral	<1%	6,940	$181K
88312		<1%	3,265	$181K
J7307	Etonogestrel (contraceptive) implant system, including implant and supplies	<1%	234	$179K
88173		<1%	2,838	$178K
77014		<1%	737	$176K
97165		<1%	3,761	$175K
77002		<1%	901	$174K
54150		<1%	311	$174K
64450		<1%	382	$174K
64636		<1%	241	$174K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	4,389	$173K
73200		<1%	492	$173K
87340		<1%	16,061	$172K
87186		<1%	13,998	$169K
93923		<1%	784	$169K
86923		<1%	3,785	$169K
74170		<1%	314	$168K
88112		<1%	3,186	$168K
72202		<1%	1,691	$165K
88184		<1%	3,606	$164K
92524		<1%	1,784	$161K
87808		<1%	12,653	$161K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	8,589	$158K
86160		<1%	7,712	$158K
80197		<1%	14,515	$158K
62322		<1%	414	$157K
73000		<1%	1,766	$157K
51600		<1%	631	$155K
J0131	Injection, acetaminophen, not otherwise specified,10 mg	<1%	14,041	$155K
84403		<1%	6,953	$154K
12002		<1%	1,129	$153K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	99,191	$152K
72146		<1%	205	$150K
90670		<1%	6,617	$149K
86762		<1%	8,378	$148K
76818		<1%	756	$147K
82570		<1%	26,342	$147K
97016		<1%	5,486	$145K
90750		<1%	1,387	$145K
93922		<1%	1,150	$144K
G0279	Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066)	<1%	6,690	$141K
76827		<1%	754	$140K
74240		<1%	786	$139K
36593		<1%	632	$139K
87081		<1%	14,664	$138K
66984	Extracapsular cataract removal with insertion of intraocular lens prosthesis	<1%	196	$136K
90686		<1%	20,773	$136K
C1781	Mesh (implantable)	<1%	304	$136K
64642		<1%	806	$135K
27130		<1%	49	$134K
73501		<1%	1,838	$134K
87497		<1%	4,011	$133K
74019		<1%	1,185	$132K
88300		<1%	6,457	$130K
D1110	Prophylaxis - adult	<1%	278	$130K
J9305	Injection, pemetrexed, not otherwise specified, 10 mg	<1%	377	$129K
J0330	Injection, succinylcholine chloride, up to 20 mg	<1%	15,006	$129K
77012		<1%	558	$129K
80305		<1%	8,685	$128K
43762		<1%	419	$128K
86706		<1%	12,333	$128K
C2617	Stent, non-coronary, temporary, without delivery system	<1%	2,369	$128K
72192		<1%	504	$127K
82670		<1%	4,841	$127K
77076		<1%	623	$127K
96401		<1%	1,489	$125K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	3,774	$125K
J0561	Injection, penicillin g benzathine, 100,000 units	<1%	705	$124K
82105		<1%	8,132	$124K
P9047	Infusion, albumin (human), 25%, 50 ml	<1%	1,526	$124K
C1788	Port, indwelling (implantable)	<1%	550	$121K
T1019	Help at home with bathing, dressing and eating, billed per 15 minutes	<1%	687	$121K
21235		<1%	56	$120K
87799		<1%	4,129	$120K
95782		<1%	112	$120K
88360		<1%	1,047	$120K
85379		<1%	8,420	$119K
97116		<1%	4,698	$117K
88313		<1%	2,449	$117K
D2930	Prefabricated stainless steel crown - primary tooth	<1%	510	$116K
83550		<1%	15,824	$114K
29075		<1%	789	$114K
92526		<1%	1,634	$112K
80076		<1%	8,997	$111K
62270		<1%	390	$111K
J9070	Cyclophosphamide, 100 mg	<1%	332	$111K
72120		<1%	907	$111K
88172		<1%	2,505	$111K
J0171	Injection, adrenalin, epinephrine, 0.1 mg	<1%	7,368	$110K
95811		<1%	127	$110K
95910		<1%	414	$108K
54640		<1%	68	$108K
81374		<1%	1,788	$107K
90697		<1%	6,100	$107K
85652		<1%	29,607	$107K
G0008	Administration of influenza virus vaccine	<1%	7,932	$106K
96450		<1%	377	$106K
78264		<1%	226	$105K
83615		<1%	17,279	$104K
83001		<1%	5,631	$104K
G0379	Direct admission of patient for hospital observation care	<1%	977	$104K
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	<1%	16,302	$103K
64415		<1%	218	$101K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	58,941	$99K
J2270	Injection, morphine sulfate, up to 10 mg	<1%	32,156	$98K
95874		<1%	1,268	$95K
92610		<1%	952	$95K
P9035	Platelets, pheresis, leukocytes reduced, each unit	<1%	208	$95K
Q0162	Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	<1%	34,070	$95K
42821		<1%	58	$94K
86255		<1%	7,730	$94K
86704		<1%	8,391	$93K
97166		<1%	1,647	$92K
25605		<1%	251	$92K
J9045	Injection, carboplatin, 50 mg	<1%	3,024	$92K
86038		<1%	9,010	$91K
88331		<1%	1,246	$91K
95716		<1%	84	$91K
86147		<1%	1,969	$90K
83655		<1%	7,293	$89K
86708		<1%	7,811	$89K
97535	Self-care/home management training, each 15 minutes	<1%	3,681	$89K
77373		<1%	88	$89K
96368		<1%	849	$89K
J3420	Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg	<1%	1,575	$88K
20550		<1%	360	$87K
84146		<1%	4,739	$87K
93285		<1%	2,130	$87K
92609		<1%	1,193	$87K
99152		<1%	7,223	$86K
J0897	Injection, denosumab, 1 mg	<1%	62	$86K
P9040	Red blood cells, leukocytes reduced, irradiated, each unit	<1%	627	$86K
82947		<1%	13,828	$86K
74328		<1%	390	$86K
76001		<1%	408	$86K
62370		<1%	564	$86K
86376		<1%	6,886	$85K
82746		<1%	6,987	$85K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	51,934	$85K
36224		<1%	12	$84K
87517		<1%	2,402	$84K
J9267	Injection, paclitaxel, 1 mg	<1%	2,443	$83K
87483		<1%	285	$83K
87205		<1%	13,372	$83K
82378		<1%	3,867	$83K
C1760	Closure device, vascular (implantable/insertable)	<1%	399	$83K
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	50,610	$83K
87653		<1%	2,325	$82K
80050	General health panel	<1%	1,971	$82K
86800		<1%	5,279	$82K
J2785	Injection, regadenoson, 0.1 mg	<1%	636	$82K
J2710	Injection, neostigmine methylsulfate, up to 0.5 mg	<1%	5,764	$82K
38222		<1%	171	$81K
29705		<1%	958	$79K
J2795	Injection, ropivacaine hydrochloride, 1 mg	<1%	7,153	$79K
82550		<1%	11,676	$78K
78018		<1%	159	$77K
J1720	Injection, hydrocortisone sodium succinate, up to 100 mg	<1%	3,633	$75K
31622		<1%	121	$75K
92523		<1%	618	$75K
93229		<1%	363	$74K
86304		<1%	3,280	$73K
96112		<1%	813	$72K
81415		<1%	35	$72K
88175	Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer	<1%	3,218	$71K
86200		<1%	6,252	$70K
74220		<1%	513	$70K
84145		<1%	2,839	$70K
29888		<1%	97	$69K
20611		<1%	110	$69K
64495		<1%	187	$68K
82652		<1%	2,546	$68K
73140		<1%	906	$67K
C1729	Catheter, drainage	<1%	1,411	$67K
J9310	Injection, rituximab, 100 mg	<1%	21	$66K
87529		<1%	989	$66K
A4648	Tissue marker, implantable, any type, each	<1%	989	$66K
Q9957	Injection, perflutren lipid microspheres, per ml	<1%	856	$66K
82610		<1%	4,187	$65K
88302		<1%	1,582	$65K
77001		<1%	370	$64K
90472	Immunization administration, each additional vaccine (list separately)	<1%	3,639	$64K
82077		<1%	3,310	$64K
J0690	Injection, cefazolin sodium, 500 mg	<1%	34,272	$63K
87102		<1%	5,122	$63K
31652		<1%	66	$62K
J1170	Injection, hydromorphone, up to 4 mg	<1%	29,456	$62K
84156		<1%	17,124	$62K
86146		<1%	1,301	$62K
84432		<1%	3,710	$62K
43259		<1%	102	$61K
83002		<1%	3,703	$60K
54163		<1%	68	$60K
87900		<1%	635	$60K
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	<1%	20,906	$59K
70250		<1%	541	$59K
J8501	Aprepitant, oral, 5 mg	<1%	1,902	$59K
49591		<1%	50	$59K
47000		<1%	66	$59K
62328		<1%	74	$58K
89051		<1%	6,155	$58K
95004	Percutaneous tests with allergenic extracts, immediate type reaction	<1%	301	$58K
J1756	Injection, iron sucrose, 1 mg	<1%	1,523	$58K
P9612	Catheterization for collection of specimen, single patient, all places of service	<1%	4,292	$58K
84600		<1%	2,943	$57K
87088		<1%	6,497	$57K
86003		<1%	1,623	$57K
J7060	5% dextrose/water (500 ml = 1 unit)	<1%	5,037	$57K
86701		<1%	5,833	$57K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	2,187	$56K
76885		<1%	252	$56K
82043		<1%	10,869	$56K
84134		<1%	4,700	$56K
83520		<1%	2,623	$55K
58300		<1%	135	$55K
51701		<1%	815	$55K
J1453	Injection, fosaprepitant, 1 mg	<1%	185	$55K
J1050	Injection, medroxyprogesterone acetate, 1 mg	<1%	1,035	$55K
J3475	Injection, magnesium sulfate, per 500 mg	<1%	15,584	$54K
93786		<1%	442	$54K
99153	Mod sedat endo service >5yrs	<1%	5,372	$54K
G2066	Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results	<1%	2,209	$54K
83540		<1%	10,156	$53K
93356		<1%	1,176	$53K
87181		<1%	3,014	$53K
G0108	Diabetes outpatient self-management training services, individual, per 30 minutes	<1%	1,154	$53K
86317		<1%	910	$52K
82248		<1%	9,148	$52K
82533		<1%	3,087	$52K
82024		<1%	1,450	$51K
G0260	Injection procedure for sacroiliac joint; provision of anesthetic, steroid and/or other therapeutic agent, with or without arthrography	<1%	104	$51K
90739		<1%	496	$50K
83993		<1%	2,822	$50K
86592		<1%	11,710	$49K
90632		<1%	1,004	$49K
84402		<1%	2,294	$49K
84550		<1%	10,485	$49K
J1650	Injection, enoxaparin sodium, 10 mg	<1%	20,915	$49K
A9500	Technetium tc-99m sestamibi, diagnostic, per study dose	<1%	1,170	$48K
88309		<1%	399	$48K
86945		<1%	906	$48K
90620		<1%	1,203	$48K
82977		<1%	7,865	$48K
64400		<1%	246	$47K
84480		<1%	3,742	$47K
93451		<1%	28	$46K
J3370	Injection, vancomycin hcl, 500 mg	<1%	8,465	$46K
C1753	Catheter, intravascular ultrasound	<1%	728	$46K
84153		<1%	3,113	$46K
82785		<1%	2,811	$46K
95117		<1%	2,574	$46K
88311		<1%	2,544	$45K
88333		<1%	758	$45K
63030		<1%	13	$45K
J1610	Injection, glucagon hydrochloride, per 1 mg	<1%	509	$45K
82803		<1%	1,865	$44K
86870		<1%	751	$44K
87341		<1%	5,233	$43K
93798		<1%	911	$43K
85347		<1%	1,922	$43K
87116		<1%	2,984	$41K
85520		<1%	1,921	$41K
87147		<1%	5,191	$41K
97113		<1%	378	$40K
96111		<1%	345	$40K
J8540	Dexamethasone, oral, 0.25 mg	<1%	17,232	$40K
93299		<1%	1,202	$39K
80143		<1%	2,202	$39K
0296T		<1%	528	$39K
36590		<1%	42	$39K
31628		<1%	93	$38K
85046		<1%	6,791	$38K
J1644	Injection, heparin sodium, per 1000 units	<1%	21,841	$38K
86431		<1%	7,580	$38K
83498		<1%	1,531	$38K
J3480	Injection, potassium chloride, per 2 meq	<1%	6,217	$37K
81508		<1%	943	$37K
A0429	Emergency ambulance ride, basic life support	<1%	605	$37K
85007		<1%	7,735	$37K
V2632	Posterior chamber intraocular lens	<1%	407	$37K
82140		<1%	2,452	$37K
Q0163	Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen	<1%	5,418	$37K
77280		<1%	159	$36K
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	3,660	$36K
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	<1%	4,313	$36K
99292		<1%	46	$35K
97750		<1%	769	$35K
27447		<1%	16	$34K
80179		<1%	2,011	$34K
29515		<1%	404	$34K
43247		<1%	31	$34K
G0121	Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk	<1%	39	$34K
86301		<1%	1,855	$33K
72195		<1%	66	$33K
60240		<1%	21	$33K
87075		<1%	1,829	$33K
85576		<1%	1,096	$33K
82010		<1%	3,578	$33K
C9463	Injection, aprepitant, 1 mg	<1%	148	$32K
82627		<1%	1,704	$32K
G0283	Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care	<1%	915	$32K
74455		<1%	125	$32K
73650		<1%	453	$32K
43275		<1%	34	$32K
84305		<1%	1,638	$32K
36500		<1%	32	$32K
C8929	Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography	<1%	72	$31K
97035		<1%	1,018	$31K
84165		<1%	3,688	$31K
J1950	Injection, leuprolide acetate (for depot suspension), per 3.75 mg	<1%	12	$31K
83519		<1%	1,751	$31K
J9190	Injection, fluorouracil, 500 mg	<1%	1,580	$31K
87184		<1%	3,879	$31K
90732		<1%	562	$31K
J1030	Injection, methylprednisolone acetate, 40 mg	<1%	2,880	$31K
G0009	Administration of pneumococcal vaccine	<1%	2,213	$30K
D2391	Resin-based composite - one surface, posterior, primary or permanent	<1%	151	$30K
76604		<1%	514	$29K
Q5121	Injection, infliximab-axxq, biosimilar, (avsola), 10 mg	<1%	15	$29K
76982		<1%	479	$29K
84450		<1%	5,240	$29K
82950		<1%	6,230	$29K
84460		<1%	5,343	$29K
94760		<1%	2,714	$28K
77062		<1%	560	$28K
90647		<1%	3,847	$28K
85384		<1%	2,280	$28K
97802		<1%	1,075	$27K
J3240	Injection, thyrotropin alpha, 0.9 mg, provided in 1.1 mg vial	<1%	26	$27K
80164		<1%	2,143	$27K
97803		<1%	1,270	$27K
82150		<1%	4,107	$27K
88237		<1%	282	$27K
20600		<1%	120	$27K
97014		<1%	807	$27K
83921		<1%	1,615	$27K
99499		<1%	65	$27K
84446		<1%	2,517	$27K
86039		<1%	3,075	$26K
84132		<1%	4,961	$26K
69631		<1%	13	$26K
96138		<1%	529	$26K
84425		<1%	1,612	$25K
91322		<1%	363	$25K
71271		<1%	1,062	$25K
86341		<1%	566	$24K
90791	Psychiatric diagnostic evaluation	<1%	687	$24K
84030		<1%	4,489	$24K
90636		<1%	327	$24K
80177		<1%	2,086	$24K
11981		<1%	164	$23K
J3473	Injection, hyaluronidase, recombinant, 1 usp unit	<1%	894	$23K
A9541	Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries	<1%	274	$23K
87206		<1%	2,817	$23K
74241		<1%	95	$23K
94621		<1%	54	$23K
83883		<1%	1,519	$23K
87338		<1%	1,653	$23K
86334		<1%	1,391	$23K
92597		<1%	384	$22K
85240		<1%	1,160	$22K
85004		<1%	4,193	$22K
D2330		<1%	79	$22K
29883		<1%	29	$22K
46600		<1%	109	$22K
64644		<1%	90	$22K
84234		<1%	420	$22K
77075		<1%	122	$22K
88280		<1%	976	$22K
70490		<1%	60	$22K
82948		<1%	2,161	$22K
85018		<1%	6,001	$21K
64483		<1%	14	$21K
82104		<1%	1,798	$21K
84157		<1%	3,862	$21K
86256		<1%	2,073	$21K
31579		<1%	69	$21K
85014		<1%	5,848	$21K
C1758	Catheter, ureteral	<1%	1,550	$21K
82103		<1%	1,884	$21K
84590		<1%	2,344	$21K
88275		<1%	137	$21K
84270		<1%	1,100	$20K
97018		<1%	1,218	$20K
90734		<1%	2,994	$20K
70545		<1%	44	$20K
81479	Unlisted molecular pathology procedure	<1%	226	$20K
J2370	Injection, phenylephrine hcl, up to 1 ml	<1%	6,354	$20K
82088		<1%	592	$20K
86665		<1%	762	$19K
83021		<1%	1,070	$19K
85246		<1%	893	$19K
L3808	Wrist hand finger orthosis, rigid without joints, may include soft interface material; straps, custom fabricated, includes fitting and adjustment	<1%	265	$19K
20552		<1%	106	$19K
90746		<1%	554	$19K
84080		<1%	2,054	$18K
88264		<1%	199	$18K
93978		<1%	79	$18K
84244		<1%	984	$18K
87220		<1%	3,010	$18K
G0103	Prostate cancer screening; prostate specific antigen test (psa)	<1%	1,374	$18K
96402		<1%	267	$18K
S5102	Adult day care, billed per day	<1%	159	$17K
J0295	Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm	<1%	5,225	$17K
J2543	Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams)	<1%	6,176	$17K
86709		<1%	2,580	$17K
30520		<1%	12	$17K
J9263	Injection, oxaliplatin, 0.5 mg	<1%	599	$17K
81596		<1%	457	$17K
96523		<1%	423	$16K
93243		<1%	169	$16K
83020		<1%	1,562	$16K
29105		<1%	196	$16K
J9370	Vincristine sulfate, 1 mg	<1%	2,593	$16K
87285		<1%	2,259	$16K
J3489	Injection, zoledronic acid, 1 mg	<1%	712	$16K
J9060	Injection, cisplatin, powder or solution, 10 mg	<1%	1,183	$16K
99406		<1%	1,810	$16K
20551		<1%	137	$16K
91321		<1%	338	$16K
80158		<1%	1,228	$16K
82247		<1%	2,430	$16K
93242		<1%	237	$15K
Q9958	High osmolar contrast material, up to 149 mg/ml iodine concentration, per ml	<1%	535	$15K
87493		<1%	621	$15K
A9503	Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries	<1%	532	$15K
82390		<1%	1,676	$15K
85097		<1%	122	$15K
J1790	Injection, droperidol, up to 5 mg	<1%	6,235	$15K
87106		<1%	1,451	$15K
86705		<1%	2,744	$15K
84481		<1%	1,015	$15K
A4565	Slings	<1%	620	$15K
90381		<1%	97	$15K
76377		<1%	110	$15K
82397		<1%	987	$15K
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	12,405	$15K
82523		<1%	1,342	$15K
J0780	Injection, prochlorperazine, up to 10 mg	<1%	3,979	$15K
J2550	Injection, promethazine hcl, up to 50 mg	<1%	7,520	$15K
81015		<1%	2,974	$15K
D7240	Removal of impacted tooth - completely bony	<1%	14	$15K
95012		<1%	487	$14K
J9171	Injection, docetaxel, 1 mg	<1%	143	$14K
J1815	Injection, insulin, per 5 units	<1%	14,704	$14K
82075		<1%	673	$14K
90834	Psychotherapy session, about 45 minutes	<1%	1,552	$14K
69421		<1%	14	$14K
43276		<1%	17	$14K
84295		<1%	3,499	$14K
A9609	Fludeoxyglucose f18 up to 15 millicuries	<1%	277	$14K
87210		<1%	1,595	$14K
C1751	Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis)	<1%	91	$14K
D1351	Sealant - per tooth	<1%	55	$13K
87641		<1%	399	$13K
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	5,953	$13K
86696		<1%	924	$13K
64616		<1%	38	$13K
93246		<1%	222	$13K
97163		<1%	193	$13K
96113		<1%	416	$13K
J2357	Injection, omalizumab, 5 mg	<1%	62	$13K
97542		<1%	267	$13K
74430		<1%	69	$13K
87177		<1%	1,224	$13K
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	11,209	$12K
J9201	Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg	<1%	831	$12K
71552		<1%	12	$12K
86777		<1%	1,142	$12K
82164		<1%	923	$12K
90710		<1%	3,870	$12K
77061		<1%	428	$12K
86308		<1%	1,419	$12K
G0010	Administration of hepatitis b vaccine	<1%	679	$12K
88271		<1%	134	$11K
90716		<1%	1,664	$11K
90681		<1%	5,295	$11K
83525		<1%	998	$11K
82085		<1%	1,251	$11K
L3933	Finger orthosis, without joints, may include soft interface, custom fabricated, includes fitting and adjustment	<1%	200	$11K
82525		<1%	1,077	$11K
80230		<1%	119	$11K
83704		<1%	341	$11K
69210		<1%	44	$11K
87640		<1%	396	$11K
82435		<1%	2,251	$11K
86695		<1%	924	$11K
83521		<1%	547	$11K
90792	Psychiatric diagnostic evaluation with medical services	<1%	582	$11K
82040		<1%	2,234	$10K
J1953	Injection, levetiracetam, 10 mg	<1%	2,196	$10K
0399T		<1%	352	$10K
87511		<1%	356	$10K
86644		<1%	784	$10K
87176		<1%	1,205	$10K
93926		<1%	52	$10K
89230		<1%	185	$10K
84207		<1%	468	$10K
82232		<1%	643	$10K
77077		<1%	164	$10K
J1642	Injection, heparin sodium, (heparin lock flush), per 10 units	<1%	13,139	$9K
93925		<1%	48	$9K
86769		<1%	339	$9K
29086		<1%	102	$9K
A6212	Foam dressing, wound cover, sterile, pad size 16 sq. in. or less, with any size adhesive border, each dressing	<1%	2,262	$9K
83937		<1%	504	$9K
84182		<1%	163	$9K
78709		<1%	15	$9K
73522		<1%	79	$9K
81206		<1%	94	$9K
74330		<1%	50	$9K
73070		<1%	193	$9K
64643		<1%	54	$9K
D2392	Resin-based composite - two surfaces, posterior, primary or permanent	<1%	36	$9K
G0109	Diabetes outpatient self-management training services, group session (2 or more), per 30 minutes	<1%	232	$9K
80299		<1%	483	$9K
85245		<1%	467	$9K
41874		<1%	31	$9K
96139		<1%	94	$8K
84252		<1%	479	$8K
G0451	Development testing, with interpretation and report, per standardized instrument form	<1%	202	$8K
83721		<1%	2,152	$8K
86612		<1%	534	$8K
83010		<1%	581	$8K
70360		<1%	101	$8K
82945		<1%	1,733	$8K
90461		<1%	3,189	$8K
86698		<1%	280	$8K
86364		<1%	2,463	$8K
87015		<1%	1,465	$8K
87901		<1%	33	$8K
J9000	Injection, doxorubicin hydrochloride, 10 mg	<1%	355	$8K
85613		<1%	906	$8K
96133		<1%	116	$8K
95165	Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials	<1%	15	$8K
77332		<1%	39	$8K
A9520	Technetium tc-99m tilmanocept, diagnostic, up to 0.5 millicuries	<1%	27	$8K
85049		<1%	1,205	$7K
86787		<1%	685	$7K
74022		<1%	85	$7K
70544		<1%	14	$7K
J9206	Injection, irinotecan, 20 mg	<1%	298	$7K
82310		<1%	1,340	$7K
G8989	Self care functional limitation, discharge status, at discharge from therapy or to end reporting	<1%	193	$7K
87350		<1%	688	$7K
H2017	Psychosocial rehabilitation, billed per 15 minutes	<1%	82	$7K
87385		<1%	487	$7K
69209		<1%	60	$7K
82810		<1%	470	$7K
75809		<1%	58	$7K
86593		<1%	1,689	$7K
76886		<1%	40	$7K
20605		<1%	29	$7K
C9113	Injection, pantoprazole sodium, per vial	<1%	2,410	$7K
C1730	Catheter, electrophysiology, diagnostic, other than 3d mapping (19 or fewer electrodes)	<1%	19	$7K
J1020	Injection, methylprednisolone acetate, 20 mg	<1%	649	$7K
J1580	Injection, garamycin, gentamicin, up to 80 mg	<1%	1,554	$7K
J3411	Injection, thiamine hcl, 100 mg	<1%	1,854	$7K
83835		<1%	459	$7K
86694		<1%	509	$6K
86707		<1%	632	$6K
86682		<1%	627	$6K
90837	Psychotherapy session, about an hour	<1%	1,254	$6K
73010		<1%	73	$6K
97167		<1%	75	$6K
89050		<1%	722	$6K
L3913	Hand finger orthosis, without joints, may include soft interface, straps, custom fabricated, includes fitting and adjustment	<1%	84	$6K
82787		<1%	365	$6K
82139		<1%	349	$6K
G0297	Low dose ct scan (ldct) for lung cancer screening	<1%	278	$6K
73503		<1%	56	$6K
A0428	Ambulance service, basic life support, non-emergency transport, (bls)	<1%	1,266	$6K
82340		<1%	1,173	$6K
A9270	Non-covered item or service	<1%	7,805	$6K
81243		<1%	142	$6K
90662		<1%	586	$6K
86381		<1%	470	$6K
J2920	Injection, methylprednisolone sodium succinate, up to 40 mg	<1%	1,656	$6K
16020		<1%	44	$6K
J0461	Injection, atropine sulfate, 0.01 mg	<1%	1,517	$6K
J9074	Injection, cyclophosphamide (sandoz), 5 mg	<1%	33	$6K
84155		<1%	2,414	$6K
80171		<1%	311	$5K
43244		<1%	12	$5K
82951		<1%	443	$5K
86331		<1%	365	$5K
90707		<1%	1,278	$5K
78999		<1%	18	$5K
J1010	Injection, methylprednisolone acetate, 1 mg	<1%	586	$5K
86606		<1%	270	$5K
78300		<1%	13	$5K
86403		<1%	576	$5K
0081A		<1%	208	$5K
87305		<1%	485	$5K
84520		<1%	1,361	$5K
72080		<1%	44	$5K
L0172	Cervical, collar, semi-rigid thermoplastic foam, two-piece, prefabricated, off-the-shelf	<1%	295	$5K
76506		<1%	27	$5K
97033		<1%	149	$5K
90480		<1%	399	$5K
91010		<1%	13	$5K
J0360	Injection, hydralazine hcl, up to 20 mg	<1%	1,820	$5K
82365		<1%	453	$5K
L1832	Knee orthosis, adjustable knee joints (unicentric or polycentric), positional orthosis, rigid support, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise	<1%	138	$5K
86905		<1%	60	$5K
84630		<1%	571	$5K
84597		<1%	449	$5K
D2331		<1%	25	$5K
80349		<1%	270	$5K
86635		<1%	245	$5K
98927		<1%	274	$5K
Q0177	Hydroxyzine pamoate, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	<1%	4,218	$5K
74175		<1%	17	$5K
87071		<1%	483	$4K
51702		<1%	61	$4K
86258		<1%	318	$4K
98929		<1%	222	$4K
87481		<1%	35	$4K
A9551	Technetium tc-99m succimer, diagnostic, per study dose, up to 10 millicuries	<1%	16	$4K
P9041	Infusion, albumin (human), 5%, 50 ml	<1%	84	$4K
Q9966	Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml	<1%	1,008	$4K
84300		<1%	882	$4K
71101		<1%	30	$4K
43249		<1%	17	$4K
M0245	Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring	<1%	13	$4K
96127		<1%	430	$4K
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	<1%	3,137	$4K
86021		<1%	276	$4K
A9562	Technetium tc-99m mertiatide, diagnostic, per study dose, up to 15 millicuries	<1%	12	$4K
96130		<1%	94	$4K
H0038	Self-help/peer services, per 15 minutes	<1%	39	$4K
82657		<1%	173	$4K
11102		<1%	28	$4K
87905		<1%	309	$4K
J2310	Injection, naloxone hydrochloride, per 1 mg	<1%	304	$4K
90380		<1%	45	$3K
T1017	Case management, billed per 15 minutes	<1%	63	$3K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	5,037	$3K
76981		<1%	59	$3K
C2625	Stent, non-coronary, temporary, with delivery system	<1%	16	$3K
11104		<1%	14	$3K
84681		<1%	186	$3K
86036		<1%	407	$3K
10022		<1%	15	$3K
12013		<1%	28	$3K
81050		<1%	786	$3K
J1956	Injection, levofloxacin, 250 mg	<1%	1,938	$3K
86363		<1%	98	$3K
99407		<1%	246	$3K
82955		<1%	458	$3K
84478		<1%	429	$3K
64405		<1%	12	$3K
85660		<1%	492	$3K
90633		<1%	5,964	$3K
90696		<1%	2,464	$3K
J2060	Injection, lorazepam, 2 mg	<1%	4,515	$3K
80175		<1%	269	$3K
17250		<1%	28	$3K
81220	CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants	<1%	18	$3K
87209		<1%	223	$3K
97760		<1%	73	$3K
97168		<1%	95	$3K
J7510	Prednisolone oral, per 5 mg	<1%	1,488	$3K
88344		<1%	15	$3K
96132		<1%	30	$3K
86352		<1%	16	$3K
20526		<1%	14	$3K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	28	$3K
86922		<1%	50	$3K
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	<1%	5,011	$3K
J1040	Injection, methylprednisolone acetate, 80 mg	<1%	369	$3K
J0692	Injection, cefepime hydrochloride, 500 mg	<1%	729	$3K
J7070	Infusion, d5w, 1000 cc	<1%	19	$3K
93750		<1%	31	$2K
96137		<1%	81	$2K
80325		<1%	127	$2K
82180		<1%	333	$2K
86141		<1%	200	$2K
90700		<1%	2,375	$2K
76983		<1%	100	$2K
99151		<1%	136	$2K
J0688	Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg	<1%	3,232	$2K
86645		<1%	133	$2K
86008		<1%	101	$2K
76098		<1%	18	$2K
82270		<1%	513	$2K
80346		<1%	125	$2K
J2919	Injection, methylprednisolone sodium succinate, 5 mg	<1%	567	$2K
85612		<1%	134	$2K
83789		<1%	138	$2K
84466		<1%	189	$2K
G0237	Therapeutic procedures to increase strength or endurance of respiratory muscles, face to face, one on one, each 15 minutes (includes monitoring)	<1%	67	$2K
J1630	Injection, haloperidol, up to 5 mg	<1%	907	$2K
86162		<1%	114	$2K
J1940	Injection, furosemide, up to 20 mg	<1%	2,097	$2K
J0137	Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg	<1%	791	$2K
88365		<1%	26	$2K
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	112	$2K
29065		<1%	13	$2K
84075		<1%	452	$2K
L4350	Ankle control orthosis, stirrup style, rigid, includes any type interface (e.g., pneumatic, gel), prefabricated, off-the-shelf	<1%	265	$2K
J1171	Injection, hydromorphone, 0.1 mg	<1%	809	$2K
36600		<1%	68	$2K
90698		<1%	974	$2K
T1016	Case management, each 15 minutes	<1%	29	$2K
J2272	Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg	<1%	1,420	$2K
82952		<1%	443	$2K
88262		<1%	14	$2K
J2003	Injection, lidocaine hydrochloride, 1 mg	<1%	2,385	$2K
96131		<1%	37	$2K
36416		<1%	281	$2K
84591		<1%	158	$2K
0556T		<1%	46	$2K
86053		<1%	34	$1K
96377		<1%	82	$1K
J0694	Injection, cefoxitin sodium, 1 gm	<1%	328	$1K
80203		<1%	130	$1K
88230		<1%	12	$1K
90656		<1%	336	$1K
94761		<1%	50	$1K
95970		<1%	13	$1K
83003		<1%	78	$1K
80348		<1%	57	$1K
S5170	Home delivered meals, including preparation; per meal	<1%	25	$1K
87449		<1%	105	$1K
J2371	Injection, phenylephrine hydrochloride, 20 micrograms	<1%	1,879	$1K
80183		<1%	117	$1K
90853	Group psychotherapy (other than of a multiple-family group)	<1%	577	$1K
J7042	5% dextrose/normal saline (500 ml = 1 unit)	<1%	419	$1K
G8979	Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	<1%	1,117	$1K
82017		<1%	69	$1K
85390		<1%	17	$1K
80353		<1%	54	$1K
88334		<1%	47	$1K
83930		<1%	212	$1K
S5161	Emergency response system; service fee, per month (excludes installation and testing)	<1%	410	$1K
86765		<1%	129	$1K
J9250	Methotrexate sodium, 5 mg	<1%	920	$1K
90733		<1%	16	$1K
86880		<1%	68	$1K
87512		<1%	40	$1K
96136		<1%	82	$1K
80354		<1%	63	$1K
83090		<1%	54	$1K
85549		<1%	56	$970.47
G9171	Voice functional limitation, current status at therapy episode outset and at reporting intervals	<1%	297	$965.33
J1805	Injection, esmolol hydrochloride, 10 mg	<1%	208	$951.36
82595		<1%	157	$950.69
84445		<1%	28	$919.08
86735		<1%	101	$907.36
90680		<1%	14	$882.03
85300		<1%	84	$814.85
87185		<1%	172	$811.14
82172		<1%	50	$794.82
J1920	Injection, labetalol hydrochloride, 5 mg	<1%	414	$794.02
G8980	Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting	<1%	309	$786.56
90832	Psychotherapy session, about 30 minutes	<1%	277	$768.17
G8985	Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	<1%	297	$759.68
J0736	Injection, clindamycin phosphate, 300 mg	<1%	125	$708.63
P9045	Infusion, albumin (human), 5%, 250 ml	<1%	16	$705.29
A4306	Disposable drug delivery system, flow rate of less than 50 ml per hour	<1%	30	$692.90
82157		<1%	26	$679.91
94664		<1%	25	$677.66
86316		<1%	42	$640.11
29130		<1%	14	$638.00
82438		<1%	152	$626.27
80178		<1%	88	$622.01
84166		<1%	44	$612.82
80201		<1%	39	$608.79
87426	Infectious agent antigen detection, SARS-CoV-2 (COVID-19)	<1%	26	$608.40
G8978	Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals	<1%	1,221	$579.71
96380		<1%	137	$578.39
93280		<1%	15	$575.02
83935		<1%	99	$533.38
77091		<1%	43	$529.85
J1596	Injection, glycopyrrolate, 0.1 mg	<1%	978	$522.60
J3360	Injection, diazepam, up to 5 mg	<1%	33	$519.46
80361		<1%	20	$504.35
J0737	Injection, clindamycin phosphate (baxter), not therapeutically equivalent to j0736, 300 mg	<1%	196	$495.17
L4360	Walking boot, pneumatic and/or vacuum, with or without joints, with or without interface material, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise	<1%	17	$484.95
J7611	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg	<1%	30	$484.05
86664		<1%	37	$463.08
80195		<1%	53	$452.11
G8987	Self care functional limitation, current status, at therapy episode outset and at reporting intervals	<1%	434	$443.56
Q0164	Prochlorperazine maleate, 5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	<1%	585	$435.69
J1626	Injection, granisetron hydrochloride, 100 mcg	<1%	313	$412.29
84105		<1%	77	$390.18
A9537	Technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries	<1%	12	$389.60
86618		<1%	25	$386.78
0346T		<1%	21	$386.75
90744		<1%	361	$383.33
99443		<1%	22	$375.01
85598		<1%	31	$361.38
85303		<1%	29	$354.75
92504		<1%	19	$353.85
84154		<1%	27	$353.74
80202		<1%	21	$346.49
86617		<1%	13	$335.03
98928		<1%	13	$332.07
96119		<1%	15	$329.76
80235		<1%	26	$325.94
A9561	Technetium tc-99m oxidronate, diagnostic, per study dose, up to 30 millicuries	<1%	12	$303.46
82375		<1%	18	$299.94
J9260	Injection, methotrexate sodium, 50 mg	<1%	144	$292.96
90648		<1%	1,268	$282.21
J0612	Injection, calcium gluconate, not otherwise specified, 10 mg	<1%	24	$260.00
85306		<1%	20	$256.87
J9181	Injection, etoposide, 10 mg	<1%	38	$254.31
82668		<1%	15	$250.56
83916		<1%	13	$247.94
86702		<1%	48	$243.47
86692		<1%	12	$241.56
86231		<1%	29	$235.63
84163		<1%	16	$233.38
L1830	Knee orthosis, immobilizer, canvas longitudinal, prefabricated, off-the-shelf	<1%	39	$230.97
84144		<1%	13	$226.33
J0574	Buprenorphine/naloxone, oral, greater than 6 mg, but less than or equal to 10 mg buprenorphine	<1%	70	$217.59
J2470	Injection, pantoprazole sodium, 40 mg	<1%	162	$212.63
82775		<1%	13	$210.70
96381		<1%	44	$203.16
82379		<1%	14	$202.44
90619		<1%	15	$197.57
85999		<1%	59	$189.75
G8998	Swallowing functional limitation, discharge status, at discharge from therapy or to end reporting	<1%	264	$168.00
83873		<1%	12	$152.03
82272		<1%	44	$147.01
87899		<1%	15	$145.68
Q0169	Promethazine hydrochloride, 12.5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	<1%	1,088	$131.92
G8988	Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	<1%	431	$125.23
86663		<1%	13	$124.41
82042		<1%	18	$123.68
98926		<1%	14	$108.60
86580		<1%	21	$102.48
88177		<1%	14	$98.29
G8984	Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals	<1%	301	$90.29
J2598	Injection, vasopressin, 1 unit	<1%	49	$82.23
90713		<1%	26	$76.68
A0433	Advanced life support, level 2 (als 2)	<1%	38	$66.44
J1836	Injection, metronidazole, 10 mg	<1%	26	$63.24
A0426	Ambulance service, advanced life support, non-emergency transport, level 1 (als 1)	<1%	20	$57.53
90474		<1%	24	$50.94
J2305	Injection, nitroglycerin, 5 mg	<1%	149	$44.21
J2274	Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg	<1%	21	$43.73
G8996	Swallowing functional limitation, current status at therapy episode outset and at reporting intervals	<1%	424	$43.35
0054A		<1%	13	$40.03
90833	Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on)	<1%	16	$33.50
J2720	Injection, protamine sulfate, per 10 mg	<1%	18	$30.98
G9174	Other speech language pathology functional limitation, current status at therapy episode outset and at reporting intervals	<1%	62	$27.96
85008		<1%	35	$17.71
J2469	Injection, palonosetron hcl, 25 mcg	<1%	13	$7.74
J7613	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg	<1%	30	$5.92
J0697	Injection, sterile cefuroxime sodium, per 750 mg	<1%	14	$1.34
G8997	Swallowing functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	<1%	406	$0.84
Q0220	Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), 300 mg	0%	137	$0.00
G9176	Other speech language pathology functional limitation, discharge status at discharge from therapy or to end reporting	0%	22	$0.00
G8981	Changing & maintaining body position functional limitation, current status, at therapy episode outset and at reporting intervals	0%	39	$0.00
G9175	Other speech language pathology functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	37	$0.00
G9173	Voice functional limitation, discharge status at discharge from therapy or to end reporting	0%	133	$0.00
G9172	Voice functional limitation, projected goal status at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	238	$0.00
G8982	Changing & maintaining body position functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	0%	39	$0.00
90723		0%	15	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialCOLLINS, CRAIG (SR VP HEALTH AFFAIRS/CFO)

Same official

Other billing entities under COLLINS, CRAIG

Full network →

Provider	Location	Paid
University of Kentucky	Lexington, KY	$4.33M
University of Kentucky	Lexington, KY	$1.95M
University of Kentucky	Lexington, KY	$1.89M
University of Kentucky	Lexington, KY	$1.44M
Uk Pediatric Therapies at Child Development Center of the Bluegrass	Lexington, KY	$306K
Uk Optical Shop	Lexington, KY	$154K
University of Kentucky	Lexington, KY	$68K
Uk LMFT Group	Lexington, KY	$22K
Uk LPP Group	Lexington, KY	$323.29
University of Kentucky	Lexington, KY	$78.63

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.